BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22931633)

  • 1. [Immunophenotypic analysis of leukemia promyelocytes in 71 patients with acute promyelocytic leukemia].
    Liu Y; Chen YT; Li JX; Zhang SH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):806-11. PubMed ID: 22931633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunophenotypic Analysis of Acute Promyelocytic Leukemia].
    Chen F; Hu YP; Wang XH; Fu S; Fu Y; Liu X; Zhang MY; Wang SK; Zhang JH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):321-5. PubMed ID: 27150985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunophenotypic features in 143 cases of acute promyelocytic leukemia].
    Sun HM; Qian SX; Wu YJ; Qiao C; Hong M; Fan L; Yang H; Zhang JF; Zhang SJ; Wu HX; Qiu HX; Lu H; Xu W; Sheng RL; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):176-9. PubMed ID: 19236773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microgranular and t(11;17)/PLZF-RARalpha variants of acute promyelocytic leukemia also present the flow cytometric pattern of CD13, CD34, and CD15 expression characteristic of PML-RARalpha gene rearrangement.
    Rizzatti EG; Portieres FL; Martins SL; Rego EM; Zago MA; Falcão RP
    Am J Hematol; 2004 May; 76(1):44-51. PubMed ID: 15114596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship of immunophenotypic features with minimal residual disease detection and gene types in 221 cases of acute promyelocytic leukemia].
    Wang YZ; Qin YZ; Jiang B; Zhu HH; Chang Y; Hao L; Li JL; Li LD; Chen SS; Huang XJ; Liu YR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):271-6. PubMed ID: 19379549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunophenotype distinction between acute promyelocytic leukaemia and CD15- CD34- HLA-DR- acute myeloid leukaemia with nucleophosmin mutations.
    Ferrari A; Bussaglia E; Úbeda J; Facchini L; Aventin A; Sierra J; Nomdedéu JF
    Hematol Oncol; 2012 Sep; 30(3):109-14. PubMed ID: 21812014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application of CD123 in detection of minimal residual disease in acute promyelocytic leukemia].
    Wang YZ; Chang Y; Zhu HH; Qin YZ; Li JL; Fu JY; Li LD; Chen SS; Huang XJ; Lu DP; Liu YR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):427-32. PubMed ID: 16800913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The biological characteristics of CD34+ CD2+ adult acute promyelocytic leukemia and the CD34 CD2 hypergranular (M3) and microgranular (M3v) phenotypes.
    Albano F; Mestice A; Pannunzio A; Lanza F; Martino B; Pastore D; Ferrara F; Carluccio P; Nobile F; Castoldi G; Liso V; Specchia G
    Haematologica; 2006 Mar; 91(3):311-6. PubMed ID: 16531253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].
    Liu YR; Wang YZ; Chen SS; Chang Y; Fu JY; Li LD; Wang H; Yu H; Jiang B; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):731-6. PubMed ID: 18457262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DRneg patients without acute promyelocytic leukemia show distinct immunophenotypic, genetic, molecular, and cytomorphologic characteristics compared to acute promyelocytic leukemia.
    Oelschlaegel U; Mohr B; Schaich M; Schäkel U; Kroschinsky F; Illmer T; Ehninger G; Thiede C
    Cytometry B Clin Cytom; 2009 Sep; 76(5):321-7. PubMed ID: 19291801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute promyelocytic leukemia: four distinct patterns by flow cytometry immunophenotyping.
    Gorczyca W
    Pol J Pathol; 2012 Mar; 63(1):8-17. PubMed ID: 22535601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection and analysis of immune molecules in leukemia cell surfaces of acute promyelocytic leukemia].
    Dong T; Jiang Y; Li Z; Ouyang H; Zhang Q
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 May; 33(5):664-667. PubMed ID: 28502306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
    Zhao F; Chen Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The triple-negative (CD34-/HLA-DR-/CD11b-) profile rapidly and specifically identifies an acute promyelocytic leukemia.
    Rahman K; Gupta R; Singh MK; Sarkar MK; Gupta A; Nityanand S
    Int J Lab Hematol; 2018 Apr; 40(2):144-151. PubMed ID: 28984423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunophenotype of acute promyelocytic leukemia (APL): an ECOG study.
    Paietta E; Andersen J; Gallagher R; Bennett J; Yunis J; Cassileth P; Rowe J; Wiernik PH
    Leukemia; 1994 Jul; 8(7):1108-12. PubMed ID: 8035602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A hypogranular variant of acute promyelocytic leukaemia showing a heterogenic immunophenotype with CD34, CD2, HLA-DR positivity: a case report and review of the literature.
    Patteet L; Vermeulen K; Pieters K; Van Assche E; Vrelust I; Gaddiseur A; Berneman ZN; Van der Planken M
    Acta Clin Belg; 2012; 67(1):34-8. PubMed ID: 22480037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunophenotypic pattern of myeloid populations by flow cytometry analysis.
    Gorczyca W; Sun ZY; Cronin W; Li X; Mau S; Tugulea S
    Methods Cell Biol; 2011; 103():221-66. PubMed ID: 21722806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The clinical and laboratory features of acute promyelocytic leukemia: an analysis of 513 cases].
    Liang JY; Wu DP; Liu YJ; Ma QF; Gong JX; Zhu MQ; Xue YQ; Chen ZX
    Zhonghua Nei Ke Za Zhi; 2008 May; 47(5):389-92. PubMed ID: 18953948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
    Liu YR; Chang Y; Ruan GR; Qin YZ; Lai YY; Shi HX; Wang YZ; Li LD; Jiang B; Li JL
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):98-103. PubMed ID: 23611213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3.
    Scott AA; Head DR; Kopecky KJ; Appelbaum FR; Theil KS; Grever MR; Chen IM; Whittaker MH; Griffith BB; Licht JD
    Blood; 1994 Jul; 84(1):244-55. PubMed ID: 7517211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.